These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 26106538

  • 1. Multiple sclerosis, cannabis, and cognition: A structural MRI study.
    Romero K, Pavisian B, Staines WR, Feinstein A.
    Neuroimage Clin; 2015; 8():140-7. PubMed ID: 26106538
    [Abstract] [Full Text] [Related]

  • 2. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
    Nocentini U, Bozzali M, Spanò B, Cercignani M, Serra L, Basile B, Mannu R, Caltagirone C, De Luca J.
    Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
    [Abstract] [Full Text] [Related]

  • 3. The impact of deep grey matter volume on cognition in multiple sclerosis.
    Lorefice L, Carta E, Frau J, Contu F, Casaglia E, Coghe G, Barracciu MA, Cocco E, Fenu G.
    Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
    [Abstract] [Full Text] [Related]

  • 4. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
    Pravatà E, Rocca MA, Valsasina P, Riccitelli GC, Gobbi C, Comi G, Falini A, Filippi M.
    Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
    [Abstract] [Full Text] [Related]

  • 5. What to make of cannabis and cognition in MS: In search of clarity amidst the haze.
    Feinstein A, Banwell E, Pavisian B.
    Mult Scler; 2015 Dec; 21(14):1755-60. PubMed ID: 26453678
    [Abstract] [Full Text] [Related]

  • 6. Cognitive impairment and its relation to imaging measures in multiple sclerosis: a study using a computerized battery.
    Pellicano C, Kane RL, Gallo A, Xiaobai L, Stern SK, Ikonomidou VN, Evangelou IE, Ohayon JM, Ehrmantraut M, Cantor FK, Bagnato F.
    J Neuroimaging; 2013 Jul; 23(3):445-52. PubMed ID: 23227967
    [Abstract] [Full Text] [Related]

  • 7. Modeling the relationship among gray matter atrophy, abnormalities in connecting white matter, and cognitive performance in early multiple sclerosis.
    Kuceyeski AF, Vargas W, Dayan M, Monohan E, Blackwell C, Raj A, Fujimoto K, Gauthier SA.
    AJNR Am J Neuroradiol; 2015 Apr; 36(4):702-9. PubMed ID: 25414004
    [Abstract] [Full Text] [Related]

  • 8. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
    Kalinowska-Łyszczarz A, Pawlak MA, Pietrzak A, Pawlak-Buś K, Leszczyński P, Puszczewicz M, Majewski D, Paprzycki W, Kozubski W, Michalak S.
    Lupus; 2018 Apr; 27(4):610-620. PubMed ID: 28992796
    [Abstract] [Full Text] [Related]

  • 9. Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis.
    Modica CM, Bergsland N, Dwyer MG, Ramasamy DP, Carl E, Zivadinov R, Benedict RH.
    Mult Scler; 2016 Jan; 22(1):36-42. PubMed ID: 25921038
    [Abstract] [Full Text] [Related]

  • 10. Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.
    Feinstein A, Meza C, Stefan C, Staines RW.
    Brain; 2019 Sep 01; 142(9):2800-2812. PubMed ID: 31363742
    [Abstract] [Full Text] [Related]

  • 11. Subclinical MRI disease activity influences cognitive performance in MS patients.
    Damasceno A, Damasceno BP, Cendes F.
    Mult Scler Relat Disord; 2015 Mar 01; 4(2):137-43. PubMed ID: 25787189
    [Abstract] [Full Text] [Related]

  • 12. Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.
    Daams M, Steenwijk MD, Schoonheim MM, Wattjes MP, Balk LJ, Tewarie PK, Killestein J, Uitdehaag BM, Geurts JJ, Barkhof F.
    Mult Scler; 2016 Apr 01; 22(5):608-19. PubMed ID: 26209593
    [Abstract] [Full Text] [Related]

  • 13. Looking into cognitive impairment in primary-progressive multiple sclerosis.
    Petracca M, Sumowski J, Fabian M, Miller A, Lublin F, Inglese M.
    Eur J Neurol; 2018 Jan 01; 25(1):192-195. PubMed ID: 29053884
    [Abstract] [Full Text] [Related]

  • 14. The grey matter correlates of impaired decision-making in multiple sclerosis.
    Muhlert N, Sethi V, Cipolotti L, Haroon H, Parker GJ, Yousry T, Wheeler-Kingshott C, Miller D, Ron M, Chard D.
    J Neurol Neurosurg Psychiatry; 2015 May 01; 86(5):530-6. PubMed ID: 25006208
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.
    Pinter D, Khalil M, Pichler A, Langkammer C, Ropele S, Marschik PB, Fuchs S, Fazekas F, Enzinger C.
    Neuroimage Clin; 2015 May 01; 7():715-20. PubMed ID: 25844323
    [Abstract] [Full Text] [Related]

  • 17. [Gray matter lesions and cognitive impairment in multiple sclerosis].
    Kawachi I, Saji E, Nishizawa M.
    Rinsho Shinkeigaku; 2014 May 01; 54(12):1060-2. PubMed ID: 25672709
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Structural networks involved in attention and executive functions in multiple sclerosis.
    Llufriu S, Martinez-Heras E, Solana E, Sola-Valls N, Sepulveda M, Blanco Y, Martinez-Lapiscina EH, Andorra M, Villoslada P, Prats-Galino A, Saiz A.
    Neuroimage Clin; 2017 May 01; 13():288-296. PubMed ID: 28050344
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.